BioSpace News Archive

New research by the innovation consultancy Enspektos, LLC, indicates that digital therapeutics, defined as technologies such as prescription drugs with embedded sensors are rapidly growing in scope and importance globally.

In a new report on healthcare organizations’ perceptions of technology vendors from across the healthcare IT software spectrum, KLAS Research has named Health Catalyst to the exclusive “A-List” of HIT companies that combine high customer satisfaction with high rates of customer retention.

3M is excited to announce FDA 510(k) clearance for its 3M™ Attest™ Super Rapid Biological Indicator (BI) System for Steam.

Orthofix International N.V. reported its financial results for the first quarter ended March 31, 2018.

Vera Whole Health has been recognized as a finalist in the 2018 Health Value Awards in the Direct Care Provider category.

Exicure, Inc. announced results from the Phase 1b clinical trial of its compound, AST-005.

Novartis announced today that the US Food and Drug Administration (FDA) has approved Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutation, as detected by an FDA-approved test, and involvement of lymph node(s), following complete resection.

PerkinElmer, Inc. reported financial results for the first quarter ended April 1, 2018.

TSO3 Inc. will hold a conference call on Wednesday, May 9, 2018 to discuss its financial results for the first quarter ended March 31, 2018.

The Wertheim family, longtime benefactors of FIU, have pledged an additional $1 million for the Nicole Wertheim College of Nursing & Health Sciences.